معرفی
Emerita Professor Jenny Martin is a distinguished academic at the University of Queensland’s Institute for Molecular Bioscience. She holds a BPharm from the Victorian College of Pharmacy and a DPhil in protein crystallography from Oxford University, supported by the prestigious 1851 Science Research Scholarship. Her postdoctoral research at Rockefeller University focused on protein structure and drug design. Since returning to Australia in 1993, she established Queensland’s first protein crystallography laboratory and has held significant fellowships, including ARC Australian Laureate and NHMRC grants. Her research spans structural biology, bacterial virulence mechanisms, and disulfide bond formation, with a focus on enzymes like DsbA and their roles in pathogenesis. She advocates for gender equity in STEM, notably proposing conference speaker gender balance guidelines.
Education: BPharm (Victorian College of Pharmacy), MPharm (Computational Chemistry), DPhil (Oxford University). Postdoctoral training at Rockefeller University. Senior roles include leadership at the Institute for Molecular Bioscience.
Research interests include structural biology of bacterial enzymes, protein folding, and oxidative stress responses. Key projects involve elucidating the structure-function relationships of DsbA proteins in pathogens like Salmonella and Burkholderia, targeting virulence factors for drug discovery. Her work bridges structural biology with antimicrobial research, emphasizing novel inhibitor design.
Publications (2022–2019) highlight structural studies of proteins involved in copper resistance, zinc transporters, and disulfide isomerases. Recent trends focus on fragment-based drug screening and antivirulence strategies.
Awards: ASBMB Roche Medal, Queensland Smart State Research Scientist award, Women in Biotech Achievement Award. Recognized for contributions to structural biology and microbial pathogenesis.
Advising: Over 20 students and postdocs listed in her labs. Grants include ARC and NHMRC funding for structural genomics and antimicrobial research. Collaborations span academia and industry, including structural proteomics pipelines.
Labs/Teams: Lead the Institute’s protein crystallography and structural biology initiatives. Co-directs projects on bacterial redox systems and drug discovery.
